MOTS-C 40mg Canada

Technical Specifications

Compound Name: MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C)
Quantity: 40mg per vial
Format: Lyophilized peptide powder
Peptide Length: 16 amino acids
Molecular Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂ (approximate)
Molecular Weight: Approximately 2174.6 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational peptide – laboratory research use only

MOTS-C 40mg Canada is supplied as a lyophilized synthetic peptide intended exclusively for laboratory and analytical applications. Each vial contains 40 milligrams of the peptide prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada.

Research Overview

MOTS-C is a mitochondrial-derived peptide encoded within the mitochondrial 12S ribosomal RNA region. It has been studied in metabolic and cellular energy research contexts due to its role in mitochondrial–nuclear communication pathways.

Research involving MOTS-C 40mg Canada generally focuses on mitochondrial signalling, cellular stress response mechanisms, and metabolic homeostasis in experimental systems. Unlike traditional peptide hormones encoded by nuclear DNA, MOTS-C originates from mitochondrial DNA, which has contributed to interest in its regulatory functions within the cell.

In laboratory and preclinical models, MOTS-C has been evaluated for its influence on metabolic gene expression, insulin signalling pathways, and adaptive responses to nutrient availability. Scientific publications describe its activity within controlled experimental frameworks involving cell cultures and animal models.

MOTS-C 40mg Canada is supplied strictly for research purposes. Any references to biological processes reflect investigational findings derived from laboratory and preclinical studies and do not imply approved clinical application.

Mechanism Overview

MOTS-C is a short peptide consisting of 16 amino acids. It is translated from a small open reading frame in mitochondrial DNA and can translocate to the nucleus under certain stress conditions in experimental models.

In laboratory research, MOTS-C has been shown to interact with cellular metabolic pathways, particularly those associated with AMP-activated protein kinase (AMPK) signalling. Activation of AMPK in experimental systems is linked to the regulation of energy balance and mitochondrial function.

Researchers studying MOTS-C 40mg Canada evaluate its role in modulating gene expression patterns related to glucose metabolism, oxidative phosphorylation, and stress adaptation. The peptide has also been examined for its capacity to influence nuclear transcription factors involved in metabolic regulation.

Mechanistic descriptions remain confined to preclinical and investigational research contexts. They are presented for educational purposes only.

Clinical Development Context

MOTS-C has been investigated primarily in preclinical studies and early exploratory human research. Published data include animal model experiments and limited human trials examining metabolic biomarkers under controlled conditions.

These studies contribute to ongoing scientific understanding of mitochondrial-derived peptides and their systemic signalling roles. However, the MOTS-C 40mg Canada-supplied in research-grade format is an investigational compound rather than an authorized pharmaceutical product.

Health Canada does not currently approve MOTS-C as a prescription medication or consumer health product. Its availability in research supply contexts reflects academic interest in mitochondrial biology and metabolic research.

Regulatory Status in Canada

Health Canada does not approve MOTS-C as a therapeutic drug, natural health product, or over-the-counter medication.

MOTS-C 40mg Canada is classified as an investigational research peptide and is supplied exclusively for laboratory and analytical use. It is not intended for human or veterinary administration.

Handling, storage, and research involving MOTS-C 40mg Canada must comply with applicable Canadian federal and provincial regulations governing chemical and laboratory materials. Research institutions are responsible for ensuring regulatory compliance.

Molecular and Structural Notes

MOTS-C is a relatively small peptide with a molecular weight of approximately 2174.6 g/mol. Its sequence includes two cysteine residues that may form a disulphide bond, contributing to structural stability in experimental conditions.

Unlike many endocrine peptides synthesized in the nucleus, MOTS-C is encoded by mitochondrial DNA, highlighting its unique biological origin. This feature has been central to research examining mitochondrial–nuclear cross-talk mechanisms.

MOTS-C 40mg Canada is typically characterized using analytical methods such as high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and purity before distribution.

The lyophilized presentation supports stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is MOTS-C 40mg Canada studied for in research?
MOTS-C 40mg Canada is being studied in laboratory settings to investigate mitochondrial signalling and metabolic pathway regulation.

Is MOTS-C approved for medical use in Canada?
No. Health Canada does not authorize it for therapeutic or consumer use.

What type of peptide is MOTS-C?
It is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.

Does MOTS-C 40mg Canada contain additives?
Unless specified in the batch documentation, the vial contains only the lyophilized peptide compound.

Can MOTS-C 40mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

MOTS-C 40mg Canada is an investigational research peptide supplied solely for laboratory and analytical use. Health Canada does not approve it as a medication, therapeutic agent, or consumer product.

The information provided on this page is educational in nature and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of MOTS-C 40mg Canada should occur only within properly equipped research facilities and in accordance with all applicable Canadian regulations and institutional guidelines.